Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mineral oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin adverse reaction |
Causative agent (attribute) |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Allergy to mineral oil (finding) |
Causative agent (attribute) |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin oral emulsion BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin+magnesium hydroxide oral emulsion BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Product containing mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Liquid paraffin [laxative] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Liquid paraffin+white soft paraffin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Product containing magnesium hydroxide and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Emulsifying ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Wool alcohols ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Product containing mineral oil and white paraffin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Emulsifying wax+liquid paraffin+white soft paraffin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Product containing isopropyl myristate and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing almond oil and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing lanolin and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing lanolin alcohol and mineral oil and paraffin wax (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mineral oil |
Inferred relationship |
Some |
|
Allergy to mineral oil (finding) |
Causative agent (attribute) |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mineral oil |
Inferred relationship |
Some |
2 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mineral oil |
Inferred relationship |
Some |
2 |
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Mineral oil- and white soft paraffin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing mineral oil and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only almond oil and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only isopropyl myristate and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Mineral oil only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Mineral oil and white paraffin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only mineral oil and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only lanolin alcohol and mineral oil and paraffin wax (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only lanolin and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only magnesium hydroxide and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Mineral oil and white soft paraffin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing mineral oil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only mineral oil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Lipid granuloma of skin caused by mineral oil (disorder) |
Causative agent (attribute) |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Magnesium hydroxide- and mineral oil-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Product containing only magnesium hydroxide and mineral oil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mineral oil |
Inferred relationship |
Some |
1 |
Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mineral oil |
Inferred relationship |
Some |
1 |